These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 24801872
1. Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer. Xu CH, Yu LK, Hao KK. PLoS One; 2014; 9(5):e96384. PubMed ID: 24801872 [Abstract] [Full Text] [Related]
2. The predictive value of delta-like3 and serum NSE in evaluating chemotherapy response and prognosis in patients with advanced small cell lung carcinoma: An observational study. Zhu C, Huang J, Jin X, Zhang C, Zhu C, Lv M, Chen S, Du X, Feng G. Medicine (Baltimore); 2024 Jun 07; 103(23):e38487. PubMed ID: 38847733 [Abstract] [Full Text] [Related]
3. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer. Fan JT, Si XH, Liao Y, Shen P. Arch Gynecol Obstet; 2013 Jan 07; 287(1):111-5. PubMed ID: 22945838 [Abstract] [Full Text] [Related]
4. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery. Zhu CB, Chen LL, Tian JJ, Su L, Wang C, Gai ZT, Du WJ, Ma GL. Ann Surg Oncol; 2012 Mar 07; 19(3):817-25. PubMed ID: 21861215 [Abstract] [Full Text] [Related]
6. Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer. Chen C, Zhu YH, Huang JA. J Cancer Res Ther; 2018 Jun 07; 14(Supplement):S336-S340. PubMed ID: 29970686 [Abstract] [Full Text] [Related]
13. High serum YKL-40 level in patients with small cell lung cancer is related to early death. Johansen JS, Drivsholm L, Price PA, Christensen IJ. Lung Cancer; 2004 Dec 07; 46(3):333-40. PubMed ID: 15541818 [Abstract] [Full Text] [Related]
15. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Thöm I, Andritzky B, Schuch G, Burkholder I, Edler L, Johansen JS, Bokemeyer C, Schumacher U, Laack E. Cancer; 2010 Sep 01; 116(17):4114-21. PubMed ID: 20564116 [Abstract] [Full Text] [Related]
16. Evaluation of the prognosis in patients with small-cell lung cancer treated by chemotherapy using tumor shrinkage rate-based radiomics. Zhou Y, Wu Z, Wang H, Zhang K, Chen H, Zhu S, Sitrakiniaina A, Wu Y, Yang S, Sun X, Li W, Lin X, Jin J. Eur J Med Res; 2024 Aug 02; 29(1):401. PubMed ID: 39095855 [Abstract] [Full Text] [Related]
17. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Shao N, Cai Q. Clin Transl Oncol; 2015 Oct 02; 17(10):772-8. PubMed ID: 26243392 [Abstract] [Full Text] [Related]
19. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer. Zhang C, Jia Y, Jia Y, Zhang X, Li K. Int J Clin Oncol; 2018 Dec 02; 23(6):1070-1075. PubMed ID: 30168089 [Abstract] [Full Text] [Related]
20. Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients. Liu T, Zhou T, Luo F, Yang Y, Zhao S, Huang Y, Zhao H, Zhang L, Zhao Y. Cancer Control; 2021 Dec 02; 28():10732748211028257. PubMed ID: 34184581 [Abstract] [Full Text] [Related] Page: [Next] [New Search]